Syntimmune

Syntimmune

Syntimmune

Founded in 2013, Syntimmune is the worlds leader in the biology of the neonatal Fc receptor (FcRn). Syntimmune's lead program targets FcRn.
Founded
2013
Raised
$84M
Follow us
Alexa global traffic share